Previous Article | Next Article ![]()
Antimicrob. Agents Chemother., 11 1997, 2374-2382, Vol 41, No. 11
M Perilli, A Felici, N Franceschini, A De Santis, L Pagani, F Luzzaro, A Oratore, GM Rossolini, JR Knox and G Amicosante
A natural TEM variant beta-lactamase was isolated from an epidemic strain
of Serratia marcescens. Nucleotide gene sequencing revealed multiple point
mutations located in the 42-to-44 tripeptide and positions 145 to 146, 178,
and 238. In addition, a glutamic acid 212 deletion was also found. The
purified enzyme was studied from a kinetic point of view, revealing the
highest catalytic efficiency (k[cat]/Km) values for ceftazidime and
aztreonam compared with the TEM-1 prototype enzyme. The in vitro resistance
correlated with kinetic parameters, and the enzyme also mediated resistance
to some penicillins and an ampicillin-clavulanic acid combination. The
mutational and kinetic changes are discussed in relation to the
three-dimensional crystallographic structure of the wild-type TEM-1 enzyme.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain
Dipartimento di Scienze e Tecnologie Biomediche, Cattedra di Chimica Biologica, Facolta di Medicina e Chirurgia, Universita degli Studi dell'Aquila, L'Aquila, Italy.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |